These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 16735607)
1. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607 [TBL] [Abstract][Full Text] [Related]
2. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106 [TBL] [Abstract][Full Text] [Related]
3. Tumor risk in disorders of sex development (DSD). Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493 [TBL] [Abstract][Full Text] [Related]
4. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975 [TBL] [Abstract][Full Text] [Related]
5. Advances in molecular markers of germ cell cancer in patients with disorders of sex development. van der Zwan YG; Cools M; Looijenga LH Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654 [TBL] [Abstract][Full Text] [Related]
6. Tumor risk in disorders of sex development. Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977 [TBL] [Abstract][Full Text] [Related]
7. Gonadal development and tumor formation at the crossroads of male and female sex determination. Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949 [TBL] [Abstract][Full Text] [Related]
8. Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors. Cools M; Honecker F; Stoop H; Veltman JD; de Krijger RR; Steyerberg E; Wolffenbuttel KP; Bokemeyer C; Lau YF; Drop SL; Looijenga LH Hum Pathol; 2006 Jan; 37(1):101-11. PubMed ID: 16360422 [TBL] [Abstract][Full Text] [Related]
9. Tumor risk and clinical follow-up in patients with disorders of sex development. Cools M; Looijenga LH Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509 [TBL] [Abstract][Full Text] [Related]
10. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development. Pyle LC; Nathanson KL Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305 [TBL] [Abstract][Full Text] [Related]
11. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467 [TBL] [Abstract][Full Text] [Related]
12. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology. Looijenga LHJ; Kao CS; Idrees MT Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757 [TBL] [Abstract][Full Text] [Related]
13. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia). Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320 [TBL] [Abstract][Full Text] [Related]
14. Gonadal tumours and DSD. Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164 [TBL] [Abstract][Full Text] [Related]
16. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162 [TBL] [Abstract][Full Text] [Related]
17. The biology of germ cell tumors in disorders of sex development. Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895 [TBL] [Abstract][Full Text] [Related]
19. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update. Ulbright TM Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396 [TBL] [Abstract][Full Text] [Related]
20. Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]